Pediatric Puzzler: He won't walk and isn't talking much—what's the next step for a 2-year-old?

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

In the almost 10 years of data collected by the research team, nearly 1.5 million antiviral medications were dispensed to pediatric patients, and oseltamivir accounted for 99.8% of those prescriptions.

The reaction, called Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), can start as a rash but can progress quickly, potentially resulting in injury to internal organs, hospitalization, and death. 

The FDA has accepted a supplemental New Drug Application (sNDA) for roflumilast cream 0.15% for the treatment of atopic dermatitis (AD) in children aged 6 years and up.